Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease

Molecular and Cellular Biochemistry
Atsuko KamijoKenjiro Kimura

Abstract

We reported that urinary L-FABP reflected the progression of chronic kidney disease (CKD). This study is aimed to evaluate the clinical significance of urinary liver type fatty acid binding protein (L-FABP) as a biomarker for monitoring CKD. Urinary L-FABP was measured using human L-FABP ELISA kit (CMIC.Co., Ltd., Tokyo, Japan). The relations between urinary L-FABP and clinical parameters were evaluated in non-diabetic CKD (n = 48) for a year. In order to evaluate the influence of serum L-FABP derived from liver upon urinary L-FABP, both serum and urinary L-FABP were simultaneously measured in patients with CKD (n = 73). For monitoring CKD, the cut-off value in urinary L-FABP was determined as 17.4 microg/g.cr. by using a receiver operating characteristics (ROC) curve. Renal function deteriorated significantly more in patients with 'high' urinary L-FABP (n = 36) than in those with 'low' L-FABP (n = 12). The decrease in creatinine clearance was accompanied by an increase in urinary L-FABP, but not in urinary protein. Serum L-FABP in patients with CKD was not correlated with urinary L-FABP. Urinary excretion of L-FABP increases with the deterioration of renal function. Serum L-FABP did not influence on urinary L-FABP. Urinary L-F...Continue Reading

References

May 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases· KamisakaK Okano
Oct 29, 2003·Circulation·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
Jan 30, 2004·The Journal of Laboratory and Clinical Medicine·Atsuko KamijoMasao Omata
Oct 7, 2004·The American Journal of Pathology·Atsuko KamijoKenjiro Kimura

❮ Previous
Next ❯

Citations

Feb 12, 2019·Annual Review of Physiology·William R Zhang, Chirag R Parikh
Nov 19, 2015·Clinical Journal of the American Society of Nephrology : CJASN·David S CooperCatherine D Krawczeski
Sep 5, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Brad H Rovin, Xiaolan Zhang
Oct 12, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Stuart L Goldstein, Prasad Devarajan
Mar 26, 2019·Current Drug Metabolism·Monika KamianowskaAnna Wasilewska
Feb 23, 2020·Journal of Veterinary Internal Medicine·Masaaki KatayamaMasao Miyazaki
Aug 26, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Hugo You-Hsien LinHung-Chen Chen
Oct 16, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Atsuko Kamijo-IkemoriKenjiro Kimura
Feb 1, 2008·Biomarkers in Medicine·Mitchell H Rosner
Nov 10, 2012·European Journal of Pediatrics·D U Sweetman, E J Molloy
Mar 10, 2016·World Journal for Pediatric & Congenital Heart Surgery·David S CooperCatherine D Krawczeski
Aug 24, 2016·International Urology and Nephrology·Meryem BenzerAslı Uluturk Tekin
Oct 17, 2007·Annual Review of Pharmacology and Toxicology·Vishal S VaidyaJoseph V Bonventre
Apr 12, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Julia M HofstraJack F M Wetzels
Jun 9, 2009·Diabetes Care·Stine E NielsenPeter Rossing
Nov 26, 2009·Nature Reviews. Nephrology·Florian Kronenberg
Oct 16, 2008·Clinical and Experimental Hypertension : CHE·Tsukasa NakamuraKoichi Node
May 21, 2013·Journal of Clinical Laboratory Analysis·Koji HirakiKenjiro Kimura
Jul 15, 2015·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Masateru OkazakiTakeshi Sugaya
Feb 17, 2019·Metabolites·Hayley AbbissRobert D Trengove
Oct 31, 2019·Archives of Toxicology·João FariaRosalinde Masereeuw
Nov 22, 2019·Frontiers in Molecular Biosciences·Kuldeep DhamaSunil Kumar Joshi
Aug 28, 2020·Journal of Gastroenterology·Masato NakaiNaoya Sakamoto
Feb 16, 2008·Current Opinion in Nephrology and Hypertension·Thomas L NickolasPrasad Devarajan
Mar 30, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Yi LiYucheng Yan
Jan 22, 2011·Current Opinion in Pediatrics·Prasad Devarajan
Oct 4, 2006·Expert Opinion on Drug Metabolism & Toxicology·Vishal S Vaidya, Joseph V Bonventre
Nov 17, 2009·European Journal of Clinical Investigation·M von EynattenP M Humpert
Mar 5, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Atsuko Kamijo-IkemoriYugo Shibagaki
Jan 24, 2013·Journal of Korean Medical Science·Eunjung ChoHyoung-Kyu Kim
Jun 14, 2016·International Journal of Nephrology·Temesgen Fiseha, Zemenu Tamir
Jun 21, 2018·Diseases·Hiroteru KamimuraShuji Terai
Aug 21, 2008·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·Maurice M A L Pelsers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Atsuko KamijoTakeshi Sugaya
Rinsho byori. The Japanese journal of clinical pathology
Atsuko Kamijo-IkemoriKenjiro Kimura
Nihon rinsho. Japanese journal of clinical medicine
Atsuko Kamijo-Ikemori, Takeshi Sugaya
© 2021 Meta ULC. All rights reserved